Expertise in
7
conditions

Richard A. Wells

25 Morton Shulman Avenue, 
Toronto, ON, CA 
Expertise in
7
conditions
25 Morton Shulman Avenue, 
Toronto, ON, CA 

Overview

Richard Wells practices practicing medicine in Toronto, Canada.

Mr. Wells is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Paroxysmal Cold Hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome (MDS), and Hemolysis.

He is actively involved in clinical research, co-authoring 52 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

25 Morton Shulman Avenue, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drugs: Cedazuridine, Decitabine
Study Phase: Phase 3

52 Total Publications

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.
Journal: American journal of hematology
Published: September 05, 2023

Frequently Asked Questions about Richard A. Wells

Is Richard A. Wells a top-rated expert for Paroxysmal Cold Hemoglobinuria?

MediFind is an objective health platform that identifies experts based on real-world data. Richard A. Wells is classified as an Distinguished expert for Paroxysmal Cold Hemoglobinuria, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Richard A. Wells participate in research or clinical trials?

Yes. Richard A. Wells has published 52 articles and abstracts on conditions like Paroxysmal Cold Hemoglobinuria. You can view a list of Richard A. Wells's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wells's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile